On the other hand, when miR‐155 and miR‐181b activity was examined in AKT‐dependent breast cancer lines, we found a strong correlation of selective sensitivity to these miRs and previously published sensitivities to chemical inhibition of AKT (Garnett et al, 2012) (Fig 2C). The gene discussed is AKT1; the disease is breast cancer.